Literature DB >> 18074381

Fragile X full mutation alleles composed of few alleles: implications for CGG repeat expansion.

Sarah L Nolin1, Xiao-hua Ding, George E Houck, W Ted Brown, Carl Dobkin.   

Abstract

Southern analysis of the FMR1 repeat region has suggested that individuals with the full mutation usually carry a heterogeneous array of FMR1 alleles in somatic tissue that can range from 200 to more than 1,000 repeats. Our studies indicate that this heterogeneity is an artifact generated by ethidium bromide commonly used in Southern analysis. When analyzed in the absence of ethidium bromide, nearly all full mutation individuals carried only one to four major alleles and did not exhibit the heterogeneity often referred to as a "smear" in the literature. Full mutations in chorionic villi, however, exhibited much greater heterogeneity. Nine transmissions from mothers with full mutation alleles to offspring indicated that the full mutations continued to expand in transmission to the next generation. In contrast, analysis of leukocyte DNA from three full mutation males revealed no change in somatic full mutation alleles over many years. Our studies support the hypothesis that the FMR1 CGG repeat instability is limited to very early embryogenesis in the soma. These studies also have clinical importance because the omission of ethidium bromide will facilitate the diagnosis of females with full mutation alleles. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18074381     DOI: 10.1002/ajmg.a.32087

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

Review 1.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

2.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

3.  The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells.

Authors:  Jeannine Gerhardt; Mark J Tomishima; Nikica Zaninovic; Dilek Colak; Zi Yan; Qiansheng Zhan; Zev Rosenwaks; Samie R Jaffrey; Carl L Schildkraut
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

Review 4.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

5.  Somatic expansion in mouse and human carriers of fragile X premutation alleles.

Authors:  Rachel Adihe Lokanga; Ali Entezam; Daman Kumari; Dmitry Yudkin; Mei Qin; Carolyn Beebe Smith; Karen Usdin
Journal:  Hum Mutat       Date:  2012-10-04       Impact factor: 4.878

Review 6.  A brief history of triplet repeat diseases.

Authors:  Helen Budworth; Cynthia T McMurray
Journal:  Methods Mol Biol       Date:  2013

7.  Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.

Authors:  Daman Kumari; Aditi Bhattacharya; Jeffrey Nadel; Kristen Moulton; Nicole M Zeak; Anne Glicksman; Carl Dobkin; David J Brick; Philip H Schwartz; Carolyn B Smith; Eric Klann; Karen Usdin
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

8.  Assays for Determining Repeat Number, Methylation Status, and AGG Interruptions in the Fragile X-Related Disorders.

Authors:  Bruce E Hayward; Karen Usdin
Journal:  Methods Mol Biol       Date:  2019

9.  Cis-acting DNA sequence at a replication origin promotes repeat expansion to fragile X full mutation.

Authors:  Jeannine Gerhardt; Nikica Zaninovic; Qiansheng Zhan; Advaitha Madireddy; Sarah L Nolin; Nicole Ersalesi; Zi Yan; Zev Rosenwaks; Carl L Schildkraut
Journal:  J Cell Biol       Date:  2014-09-01       Impact factor: 10.539

10.  EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders.

Authors:  Valérie Biancalana; Dieter Glaeser; Shirley McQuaid; Peter Steinbach
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.